Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3772

1.

The SLC40A1 R178Q mutation is a recurrent cause of hemochromatosis and is associated with a novel pathogenic mechanism.

Ka C, Guellec J, Perpermans X, Kannengiesser C, Ged C, Wuyts W, Cassiman D, de Ledinghen V, Varet B, de Kerguenec C, Oudin C, Gourlaouen I, Lefebvre T, FĂ©rec C, Callebaut I, Le Gac G; French National Network for the Molecular Diagnosis of Inherited Iron Overload Disorders.

Haematologica. 2018 Jul 12. pii: haematol.2018.189845. doi: 10.3324/haematol.2018.189845. [Epub ahead of print]

PMID:
30002125
2.

Serum Markers of Iron Metabolism in Chronic Liver Diseases.

Radicheva MP, Andonova AN, Milcheva HT, Ivanova NG, Kyuchukova SG, Nikolova MS, Platikanova AS.

Open Access Maced J Med Sci. 2018 Jun 14;6(6):1010-1016. doi: 10.3889/oamjms.2018.251. eCollection 2018 Jun 20.

3.

Iron Homeostasis Pathways as Therapeutic Targets in Acute Kidney Injury.

Swaminathan S.

Nephron. 2018 Jul 6:1-4. doi: 10.1159/000490808. [Epub ahead of print]

4.

Erythropoietic regulators of iron metabolism.

Ganz T.

Free Radic Biol Med. 2018 Jul 5. pii: S0891-5849(18)31188-2. doi: 10.1016/j.freeradbiomed.2018.07.003. [Epub ahead of print]

PMID:
29981834
5.

Phenotyping rare hepcidin deficiency.

Bardou-Jacquet E.

Blood. 2018 Jul 5;132(1):7-8. doi: 10.1182/blood-2018-05-851634. No abstract available.

PMID:
29976780
6.

Investigational hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHI) for the treatment of anemia associated with chronic kidney disease.

Del Vecchio L, Locatelli F.

Expert Opin Investig Drugs. 2018 Jul 12:1-9. doi: 10.1080/13543784.2018.1493455. [Epub ahead of print]

PMID:
29975110
8.

Transferrin and transferrin receptors update.

Kawabata H.

Free Radic Biol Med. 2018 Jun 30. pii: S0891-5849(18)31160-2. doi: 10.1016/j.freeradbiomed.2018.06.037. [Epub ahead of print]

PMID:
29969719
9.

Effects of Single-Walled Carbon Nanotube on the Conformation of Human Hepcidin: Molecular Dynamics Simulation and Binding Free Energy Calculations.

Rasoolzadeh R, Mehrnejad F, Taghdir M, Yaghmaei P.

J Biomol Struct Dyn. 2018 Jul 2:1-24. doi: 10.1080/07391102.2018.1477624. [Epub ahead of print]

PMID:
29962328
10.

Misdistribution of Iron and Oxidative Stress in Chronic Kidney Disease.

Nakanishi T, Kuragano T, Nanami M, Nagasawa Y, Hasuike Y.

Free Radic Biol Med. 2018 Jun 26. pii: S0891-5849(18)31115-8. doi: 10.1016/j.freeradbiomed.2018.06.025. [Epub ahead of print]

PMID:
29958932
11.

Prognostic Value of Iron-Homeostasis Regulating Peptide Hepcidin in Coronary Heart Disease-Evidence from the Large AtheroGene Study.

Zeller T, Altay A, Waldeyer C, Appelbaum S, Ojeda F, Ruhe J, Schnabel RB, Lackner KJ, Blankenberg S, Karakas M.

Biomolecules. 2018 Jun 28;8(3). pii: E43. doi: 10.3390/biom8030043.

12.

When should iron supplementation in dialysis patients be avoided, minimized or withdrawn?

Rostoker G.

Semin Dial. 2018 Jun 28. doi: 10.1111/sdi.12732. [Epub ahead of print]

PMID:
29956370
13.

Markers of Anemia in Children with Type 1 Diabetes.

Rusak E, Rotarska-Mizera A, Adamczyk P, Mazur B, Polanska J, Chobot A.

J Diabetes Res. 2018 May 31;2018:5184354. doi: 10.1155/2018/5184354. eCollection 2018.

14.

Knockdown of ferroportin accelerates erastin-induced ferroptosis in neuroblastoma cells.

Geng N, Shi BJ, Li SL, Zhong ZY, Li YC, Xua WL, Zhou H, Cai JH.

Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3826-3836. doi: 10.26355/eurrev_201806_15267.

PMID:
29949159
15.

Study of melatonin-mediated effects on various hepatic inflammatory responses stimulated by IL-6 in a new HepG2-on-a-chip platform.

Jang M, Manz A, Volk T, Kleber A.

Biomed Microdevices. 2018 Jun 26;20(3):54. doi: 10.1007/s10544-018-0300-x.

PMID:
29946898
16.

Commentary: Iron deficiency of pregnancy - a new approach involving intravenous iron.

Auerbach M.

Reprod Health. 2018 Jun 22;15(Suppl 1):96. doi: 10.1186/s12978-018-0536-1.

17.

Iron Deficiency is Prevalent among HIV-Infected Kenyan Adults and is Better Measured by Soluble Transferrin Receptor than Ferritin.

Frosch AEP, Ayodo G, Odhiambo EO, Ireland K, Vulule J, Cusick SE.

Am J Trop Med Hyg. 2018 Jun 25. doi: 10.4269/ajtmh.18-0208. [Epub ahead of print]

PMID:
29943722
18.

Serum Hepcidin Levels in Children with Beta Thalassemia Major.

Jagadishkumar K, Yerraguntla N, Vaddambal MG.

Indian Pediatr. 2018 Jun 13. pii: S097475591600126. [Epub ahead of print]

PMID:
29941702
19.

Advances in understanding iron metabolism and its crosstalk with erythropoiesis.

Camaschella C, Pagani A.

Br J Haematol. 2018 Jun 25. doi: 10.1111/bjh.15403. [Epub ahead of print] Review.

PMID:
29938779
20.

Higher serum levels of pro-hepcidin in patients with Parkinson's disease treated with deep brain stimulation.

Kwiatek-Majkusiak J, Geremek M, Koziorowski D, Tomasiuk R, Szlufik S, Friedman A.

Neurosci Lett. 2018 Jun 18. pii: S0304-3940(18)30434-8. doi: 10.1016/j.neulet.2018.06.031. [Epub ahead of print]

PMID:
29928951

Supplemental Content

Loading ...
Support Center